Harvest Fund Management Co., Ltd

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1694126 BEIJING, F4

Position in HALO

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$581,702

+$82,500 QoQ

Shares Held

7,432

-3.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#371

of 664 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Harvest Fund Management Co., Ltd holds $18,814,641 across 10 Biotechnology names. HALO ranks #4 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	19,560	$9,716,038
2	REGN	Regeneron Pharmaceuticals, Inc.	7,900	$4,925,966
3	ALNY	Alnylam Pharmaceuticals, Inc.	9,981	$3,004,580
4	HALO	Halozyme Therapeutics, Inc. This page	7,432	$581,702
5	EXEL	Exelixis, Inc.	7,699	$418,902
6	BBIO	BridgeBio Pharma, Inc.	892	$66,436
7	BNTX	BioNTech SE	600	$55,830
8	INCY	Incyte Corp	184	$20,858

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$581,702	7,432	-3.8%	Shares	Sole	2026-08-20
2026-03-31	$499,202	7,724	+57.8%	Shares	Sole	2026-05-14
2025-12-31	$329,366	4,894	0.0%	Shares	Sole	2026-02-11
2025-09-30	$358,925	4,894	+97780.0%	Shares	Sole	2025-11-14
2025-06-30	$260	5	-99.6%	Shares	Sole	2025-08-15
2025-03-31	$88,823	1,392	-51.1%	Shares	Sole	2025-05-08
2024-09-30	$163,076	2,849	+184.3%	Shares	Sole	2024-11-13
2022-12-31	$57,013	1,002	-49.2%	Shares	Sole	2023-02-06
2022-06-30	$86,812	1,973	+317.1%	Shares	Sole	2022-08-11
2021-09-30	$19,241	473	-43.6%	Shares	Sole	2021-11-15
2021-06-30	$38,098	839	-50.0%	Shares	Sole	2021-08-11
2021-03-31	$69,914	1,677	0.0%	Shares	Sole	2021-05-13
2020-12-31	$71,624	1,677	0.0%	Shares	Sole	2021-02-10
2020-09-30	$44,071	1,677	—	Shares	Sole	2020-11-04
No filing history on record for this holder in this stock.